Teichmann Sarah A.
Director at TXG
- Sold, on record
- $579k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Aug 14, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TXG10x Genomics, Inc.Director
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice TXGNoticeFeb 25, 2026 2026
Filed to sell 7,579 shares ($147k)
Teichmann Sarah A., Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale TXGRoutineFeb 25, 2026 same day
Sold 7,579 shares at $19.41 ($147k)
Teichmann Sarah A., Director
10b5-1 planSold 22.1% of holdings ($667k position)26,780 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice TXGNoticeAug 13, 2026 +169 days
Filed to sell 5,278 shares ($302k)
Teichmann Sarah A., Director
10b5-1 planFiling
- 4 Form 144 notice TXGNoticeAug 14, 2026 +1 day
Filed to sell 2,273 shares ($130k)
Teichmann Sarah A., Director
10b5-1 planFiling
- 5 Form 4 sale TXGRoutineAug 14, 2026 same day
Sold 7,551 shares at $57.25 ($432k)
Teichmann Sarah A., Director
10b5-1 planSold 21.2% of holdings ($2M position)28,058 shares leftFollows a Form 144Filing
- 6 Form 144 notice TXGNoticeNov 20, 2026 +98 days
Filed to sell 4,000 shares ($223k)
Teichmann Sarah A., Director
10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2026 | Nov 20, 2026 | TXG | Director | Form 144 notice | 4,000 | $223k | Notice | SEC | |
| Aug 14, 2026 | Aug 17, 2026 | TXG | Director | Form 4 sale | 7,551 | $432k | 21.2% | Routine | SEC |
| Aug 14, 2026 | Aug 14, 2026 | TXG | Director | Form 144 notice | 2,273 | $130k | Notice | SEC | |
| Aug 13, 2026 | Aug 13, 2026 | TXG | Director | Form 144 notice | 5,278 | $302k | Notice | SEC | |
| Feb 25, 2026 | Feb 27, 2026 | TXG | Director | Form 4 sale | 7,579 | $147k | 22.1% | Routine | SEC |
| Feb 25, 2026 | Feb 25, 2026 | TXG | Director | Form 144 notice | 7,579 | $147k | Notice | SEC |